Literature DB >> 15678104

The profile of repeat-associated histone lysine methylation states in the mouse epigenome.

Joost H A Martens1, Roderick J O'Sullivan, Ulrich Braunschweig, Susanne Opravil, Martin Radolf, Peter Steinlein, Thomas Jenuwein.   

Abstract

Histone lysine methylation has been shown to index silenced chromatin regions at, for example, pericentric heterochromatin or of the inactive X chromosome. Here, we examined the distribution of repressive histone lysine methylation states over the entire family of DNA repeats in the mouse genome. Using chromatin immunoprecipitation in a cluster analysis representing repetitive elements, our data demonstrate the selective enrichment of distinct H3-K9, H3-K27 and H4-K20 methylation marks across tandem repeats (e.g. major and minor satellites), DNA transposons, retrotransposons, long interspersed nucleotide elements and short interspersed nucleotide elements. Tandem repeats, but not the other repetitive elements, give rise to double-stranded (ds) RNAs that are further elevated in embryonic stem (ES) cells lacking the H3-K9-specific Suv39h histone methyltransferases. Importantly, although H3-K9 tri- and H4-K20 trimethylation appear stable at the satellite repeats, many of the other repeat-associated repressive marks vary in chromatin of differentiated ES cells or of embryonic trophoblasts and fibroblasts. Our data define a profile of repressive histone lysine methylation states for the repetitive complement of four distinct mouse epigenomes and suggest tandem repeats and dsRNA as primary triggers for more stable chromatin imprints.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15678104      PMCID: PMC549616          DOI: 10.1038/sj.emboj.7600545

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  64 in total

1.  Initial sequencing and analysis of the human genome.

Authors:  E S Lander; L M Linton; B Birren; C Nusbaum; M C Zody; J Baldwin; K Devon; K Dewar; M Doyle; W FitzHugh; R Funke; D Gage; K Harris; A Heaford; J Howland; L Kann; J Lehoczky; R LeVine; P McEwan; K McKernan; J Meldrim; J P Mesirov; C Miranda; W Morris; J Naylor; C Raymond; M Rosetti; R Santos; A Sheridan; C Sougnez; Y Stange-Thomann; N Stojanovic; A Subramanian; D Wyman; J Rogers; J Sulston; R Ainscough; S Beck; D Bentley; J Burton; C Clee; N Carter; A Coulson; R Deadman; P Deloukas; A Dunham; I Dunham; R Durbin; L French; D Grafham; S Gregory; T Hubbard; S Humphray; A Hunt; M Jones; C Lloyd; A McMurray; L Matthews; S Mercer; S Milne; J C Mullikin; A Mungall; R Plumb; M Ross; R Shownkeen; S Sims; R H Waterston; R K Wilson; L W Hillier; J D McPherson; M A Marra; E R Mardis; L A Fulton; A T Chinwalla; K H Pepin; W R Gish; S L Chissoe; M C Wendl; K D Delehaunty; T L Miner; A Delehaunty; J B Kramer; L L Cook; R S Fulton; D L Johnson; P J Minx; S W Clifton; T Hawkins; E Branscomb; P Predki; P Richardson; S Wenning; T Slezak; N Doggett; J F Cheng; A Olsen; S Lucas; C Elkin; E Uberbacher; M Frazier; R A Gibbs; D M Muzny; S E Scherer; J B Bouck; E J Sodergren; K C Worley; C M Rives; J H Gorrell; M L Metzker; S L Naylor; R S Kucherlapati; D L Nelson; G M Weinstock; Y Sakaki; A Fujiyama; M Hattori; T Yada; A Toyoda; T Itoh; C Kawagoe; H Watanabe; Y Totoki; T Taylor; J Weissenbach; R Heilig; W Saurin; F Artiguenave; P Brottier; T Bruls; E Pelletier; C Robert; P Wincker; D R Smith; L Doucette-Stamm; M Rubenfield; K Weinstock; H M Lee; J Dubois; A Rosenthal; M Platzer; G Nyakatura; S Taudien; A Rump; H Yang; J Yu; J Wang; G Huang; J Gu; L Hood; L Rowen; A Madan; S Qin; R W Davis; N A Federspiel; A P Abola; M J Proctor; R M Myers; J Schmutz; M Dickson; J Grimwood; D R Cox; M V Olson; R Kaul; C Raymond; N Shimizu; K Kawasaki; S Minoshima; G A Evans; M Athanasiou; R Schultz; B A Roe; F Chen; H Pan; J Ramser; H Lehrach; R Reinhardt; W R McCombie; M de la Bastide; N Dedhia; H Blöcker; K Hornischer; G Nordsiek; R Agarwala; L Aravind; J A Bailey; A Bateman; S Batzoglou; E Birney; P Bork; D G Brown; C B Burge; L Cerutti; H C Chen; D Church; M Clamp; R R Copley; T Doerks; S R Eddy; E E Eichler; T S Furey; J Galagan; J G Gilbert; C Harmon; Y Hayashizaki; D Haussler; H Hermjakob; K Hokamp; W Jang; L S Johnson; T A Jones; S Kasif; A Kaspryzk; S Kennedy; W J Kent; P Kitts; E V Koonin; I Korf; D Kulp; D Lancet; T M Lowe; A McLysaght; T Mikkelsen; J V Moran; N Mulder; V J Pollara; C P Ponting; G Schuler; J Schultz; G Slater; A F Smit; E Stupka; J Szustakowki; D Thierry-Mieg; J Thierry-Mieg; L Wagner; J Wallis; R Wheeler; A Williams; Y I Wolf; K H Wolfe; S P Yang; R F Yeh; F Collins; M S Guyer; J Peterson; A Felsenfeld; K A Wetterstrand; A Patrinos; M J Morgan; P de Jong; J J Catanese; K Osoegawa; H Shizuya; S Choi; Y J Chen; J Szustakowki
Journal:  Nature       Date:  2001-02-15       Impact factor: 49.962

Review 2.  The centromere paradox: stable inheritance with rapidly evolving DNA.

Authors:  S Henikoff; K Ahmad; H S Malik
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

Review 3.  Translating the histone code.

Authors:  T Jenuwein; C D Allis
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

4.  Transcriptional silencing and promoter methylation triggered by double-stranded RNA.

Authors:  M F Mette; W Aufsatz; J van der Winden; M A Matzke; A J Matzke
Journal:  EMBO J       Date:  2000-10-02       Impact factor: 11.598

5.  A similarity between viral defense and gene silencing in plants.

Authors:  F Ratcliff; B D Harrison; D C Baulcombe
Journal:  Science       Date:  1997-06-06       Impact factor: 47.728

6.  DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.

Authors:  M Okano; D W Bell; D A Haber; E Li
Journal:  Cell       Date:  1999-10-29       Impact factor: 41.582

7.  Transitions in distinct histone H3 methylation patterns at the heterochromatin domain boundaries.

Authors:  C D Allis; S I Grewal
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

8.  Histone hypomethylation is an indicator of epigenetic plasticity in quiescent lymphocytes.

Authors:  Jonathan Baxter; Stephan Sauer; Antoine Peters; Rosalind John; Ruth Williams; Marie-Laure Caparros; Katharine Arney; Arie Otte; Thomas Jenuwein; Matthias Merkenschlager; Amanda G Fisher
Journal:  EMBO J       Date:  2004-10-28       Impact factor: 11.598

9.  Su(var) genes regulate the balance between euchromatin and heterochromatin in Drosophila.

Authors:  Anja Ebert; Gunnar Schotta; Sandro Lein; Stefan Kubicek; Veiko Krauss; Thomas Jenuwein; Gunter Reuter
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

10.  Role of transposable elements in heterochromatin and epigenetic control.

Authors:  Zachary Lippman; Anne-Valérie Gendrel; Michael Black; Matthew W Vaughn; Neilay Dedhia; W Richard McCombie; Kimberly Lavine; Vivek Mittal; Bruce May; Kristin D Kasschau; James C Carrington; Rebecca W Doerge; Vincent Colot; Rob Martienssen
Journal:  Nature       Date:  2004-07-22       Impact factor: 49.962

View more
  314 in total

1.  Integrating one-dimensional and three-dimensional maps of genomes.

Authors:  Natalia Naumova; Job Dekker
Journal:  J Cell Sci       Date:  2010-06-15       Impact factor: 5.285

2.  The mutational spectrum of non-CpG DNA varies with CpG content.

Authors:  Jean-Claude Walser; Anthony V Furano
Journal:  Genome Res       Date:  2010-05-24       Impact factor: 9.043

3.  Pathology tissue-chromatin immunoprecipitation, coupled with high-throughput sequencing, allows the epigenetic profiling of patient samples.

Authors:  Mirco Fanelli; Stefano Amatori; Iros Barozzi; Matias Soncini; Roberto Dal Zuffo; Gabriele Bucci; Maria Capra; Micaela Quarto; Gaetano Ivan Dellino; Ciro Mercurio; Myriam Alcalay; Giuseppe Viale; Pier Giuseppe Pelicci; Saverio Minucci
Journal:  Proc Natl Acad Sci U S A       Date:  2010-11-24       Impact factor: 11.205

4.  Broad chromosomal domains of histone modification patterns in C. elegans.

Authors:  Tao Liu; Andreas Rechtsteiner; Thea A Egelhofer; Anne Vielle; Isabel Latorre; Ming-Sin Cheung; Sevinc Ercan; Kohta Ikegami; Morten Jensen; Paulina Kolasinska-Zwierz; Heidi Rosenbaum; Hyunjin Shin; Scott Taing; Teruaki Takasaki; A Leonardo Iniguez; Arshad Desai; Abby F Dernburg; Hiroshi Kimura; Jason D Lieb; Julie Ahringer; Susan Strome; X Shirley Liu
Journal:  Genome Res       Date:  2010-12-22       Impact factor: 9.043

5.  Setdb1-mediated histone H3K9 hypermethylation in neurons worsens the neurological phenotype of Mecp2-deficient mice.

Authors:  Yan Jiang; Anouch Matevossian; Yin Guo; Schahram Akbarian
Journal:  Neuropharmacology       Date:  2010-09-30       Impact factor: 5.250

Review 6.  Epigenetic modifications in pluripotent and differentiated cells.

Authors:  Alexander Meissner
Journal:  Nat Biotechnol       Date:  2010-10       Impact factor: 54.908

7.  Setdb1 histone methyltransferase regulates mood-related behaviors and expression of the NMDA receptor subunit NR2B.

Authors:  Yan Jiang; Mira Jakovcevski; Rahul Bharadwaj; Caroline Connor; Frederick A Schroeder; Cong L Lin; Juerg Straubhaar; Gilles Martin; Schahram Akbarian
Journal:  J Neurosci       Date:  2010-05-26       Impact factor: 6.167

8.  Histone-lysine N-methyltransferase SETDB1 is required for development of the bovine blastocyst.

Authors:  Michael C Golding; Matthew Snyder; Gayle L Williamson; Kylee J Veazey; Michael Peoples; Jane H Pryor; Mark E Westhusin; Charles R Long
Journal:  Theriogenology       Date:  2015-07-29       Impact factor: 2.740

Review 9.  Post-transcriptional regulation of LINE-1 retrotransposition by AID/APOBEC and ADAR deaminases.

Authors:  Elisa Orecchini; Loredana Frassinelli; Silvia Galardi; Silvia Anna Ciafrè; Alessandro Michienzi
Journal:  Chromosome Res       Date:  2018-02-02       Impact factor: 5.239

10.  Sensitivity of human prostate cancer cells to chemotherapeutic drugs depends on EndoG expression regulated by promoter methylation.

Authors:  Xiaoying Wang; Volodymyr Tryndyak; Eugene O Apostolov; Xiaoyan Yin; Sudhir V Shah; Igor P Pogribny; Alexei G Basnakian
Journal:  Cancer Lett       Date:  2008-06-18       Impact factor: 8.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.